ZFIN ID: ZDB-FISH-150901-6764
Fish name: selenohhi2737Tg/hi2737Tg
Genotype: selenohhi2737Tg/hi2737Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by selenohhi2737Tg/hi2737Tg
No data available
GENE EXPRESSION
Gene expression in selenohhi2737Tg/hi2737Tg
Protein expression
Antibody Antigen Genes Structure Conditions Figures
Ab11-tp53 tp53 standard conditions Fig. 5 with image from Cox et al., 2016
Reporter gene expression No data available
PHENOTYPE
Phenotype in selenohhi2737Tg/hi2737Tg
Phenotype Conditions Figures
cartilage development process quality, abnormal standard conditions Fig. S5 with image from Cox et al., 2016
digestive tract development disrupted, abnormal standard conditions Fig. S1 with image from Cox et al., 2016
DNA damage response, detection of DNA damage process quality, abnormal ultraviolet light Fig. 5 with image from Cox et al., 2016
DNA damage response, detection of DNA damage process quality, abnormal chemical treatment: camptothecin Fig. 5 with image from Cox et al., 2016
DNA damage response, signal transduction by p53 class mediator process quality, abnormal standard conditions Fig. 4 from Cox et al., 2016
embryonic viscerocranium morphogenesis process quality, abnormal standard conditions Fig. S5 with image from Cox et al., 2016
eye decreased size, abnormal standard conditions Fig. 5 with image from Cox et al., 2016
text only from Amsterdam et al., 2004
gut decreased size, abnormal standard conditions Fig. 5 with image from Cox et al., 2016
gut hypoplastic, abnormal standard conditions text only from Amsterdam et al., 2004
head selenoh expression absent, abnormal standard conditions Fig. S1 with image from Cox et al., 2016
head decreased size, abnormal standard conditions text only from Amsterdam et al., 2004
hepatocyte apoptotic, abnormal standard conditions Fig. 5 with image from Cox et al., 2016
hepatocyte ballooning, abnormal standard conditions Fig. 5 with image from Cox et al., 2016
inflammatory response increased occurrence, abnormal standard conditions Fig. 4 from Cox et al., 2016
intestine fabp2 expression decreased amount, abnormal standard conditions Fig. S1 with imageFig. S4 with image from Cox et al., 2016
liver fabp10a expression decreased amount, abnormal standard conditions Fig. S1 with imageFig. S4 with image from Cox et al., 2016
liver decreased size, abnormal standard conditions Fig. 5 with image from Cox et al., 2016
liver hypoplastic, abnormal standard conditions text only from Amsterdam et al., 2004
liver development disrupted, abnormal standard conditions Fig. S1 with image from Cox et al., 2016
neuron elavl3 expression decreased amount, abnormal standard conditions Fig. S5 with image from Cox et al., 2016
pancreas prss1 expression decreased amount, abnormal standard conditions Fig. S1 with imageFig. S4 with image from Cox et al., 2016
pancreas decreased size, abnormal standard conditions Fig. 5 with image from Cox et al., 2016
pancreas development disrupted, abnormal standard conditions Fig. S1 with image from Cox et al., 2016
pericardium edematous, abnormal standard conditions text only from Amsterdam et al., 2004
post-vent region curved, abnormal chemical treatment: menadione Fig. 3 with image from Cox et al., 2016
response to oxidative stress process quality, abnormal standard conditions Fig. 3 with image from Cox et al., 2016
trunk curved, abnormal chemical treatment: menadione Fig. 3 with image from Cox et al., 2016
whole organism dead, abnormal ultraviolet light Fig. 5 with image from Cox et al., 2016
whole organism dead, abnormal chemical treatment: camptothecin Fig. 5 with image from Cox et al., 2016
whole organism dead, abnormal standard conditions Fig. 1 with image from Cox et al., 2016
whole organism elavl3 expression decreased amount, abnormal standard conditions Fig. S5 with image from Cox et al., 2016
whole organism decreased life span, abnormal standard conditions Fig. 1 with image from Cox et al., 2016
whole organism decreased life span, abnormal ultraviolet light Fig. 5 with image from Cox et al., 2016
whole organism decreased life span, abnormal chemical treatment: camptothecin Fig. 5 with image from Cox et al., 2016
whole organism edematous, abnormal chemical treatment: menadione Fig. 3 with image from Cox et al., 2016
whole organism lifrb expression increased amount, abnormal standard conditions Fig. 4 from Cox et al., 2016
whole organism rps27l expression increased amount, abnormal standard conditions Fig. 4 from Cox et al., 2016
whole organism mdm2 expression increased amount, abnormal standard conditions Fig. 4 from Cox et al., 2016
whole organism socs3b expression increased amount, abnormal standard conditions Fig. 4 from Cox et al., 2016
whole organism ccng1 expression increased amount, abnormal standard conditions Fig. 4 from Cox et al., 2016
whole organism tp53 expression increased amount, abnormal standard conditions Fig. 4Fig. 5 with image from Cox et al., 2016
whole organism il11a expression increased amount, abnormal standard conditions Fig. 4 from Cox et al., 2016
whole organism tnfa expression increased amount, abnormal standard conditions Fig. 4 from Cox et al., 2016
whole organism necrotic, abnormal chemical treatment: menadione Fig. 3 with image from Cox et al., 2016
whole organism cell cycle process quality, abnormal standard conditions Fig. S4 with image from Cox et al., 2016
whole organism cell redox homeostasis disrupted, abnormal standard conditions Fig. 2 from Cox et al., 2016

CITATIONS  (4)